For decades, the public health mantra regarding nutrition has often felt monolithic: "Eat this, avoid that, and you will see these results." Yet, when it comes to low-carbohydrate diets, the real-world data has consistently defied such simple equations. While one individual may shed weight and stabilize their blood sugar on a low-carb regimen, another may witness a concerning spike in their low-density lipoprotein (LDL) cholesterol—the "bad" cholesterol linked to heart disease.
New research presented at NUTRITION 2026, the flagship annual meeting of the American Society for Nutrition, offers a compelling explanation for this clinical paradox. The findings suggest that the answer lies not just in the composition of our plates, but in the intricate architecture of our genomes. By analyzing the interaction between dietary saturated fat and polygenic risk, scientists are moving closer to a future of precision nutrition, where "one size fits all" is replaced by an individualized understanding of metabolic health.
The Mystery of Metabolic Heterogeneity
The inconsistency in how people respond to low-carbohydrate diets has long been a source of frustration for both clinicians and patients. Historically, nutritional studies have struggled to account for the vast differences in individual physiology. Some adherents of low-carb diets report miraculous improvements in cardiovascular biomarkers, while others find their LDL cholesterol levels climbing, potentially offsetting the benefits of weight loss and glycemic control.
"Our findings suggest that some individuals may be more sensitive to the LDL cholesterol-raising effects of saturated fat, particularly in the context of a low-carbohydrate diet, because of their genetic background," explains Dr. Alexa Barad, PhD, RDN, a postdoctoral scholar at the Stanford University School of Medicine.
This research underscores a critical reality: nutritional science is transitioning away from the era of blanket recommendations. "Dietary conversations can sometimes become overly simplified," Dr. Barad notes. "One person may say, ‘Low-carb diets always raise LDL cholesterol,’ while another says, ‘My LDL cholesterol did not change at all.’ Our findings suggest that both experiences can be true, depending, at least in part, on the individual’s genetic makeup."
Chronology of a Breakthrough: The DIETFITS Analysis
To unravel this complex relationship, researchers turned to the data from the landmark DIETFITS (Diet Intervention Examining The Factors Interacting with Treatment Success) trial. This randomized controlled trial was originally designed to settle the debate between low-carb and low-fat dietary patterns, tracking more than 600 adults over the course of a year.
Phase 1: Re-evaluating the DIETFITS Cohort
While the initial DIETFITS results showed no significant difference in weight loss outcomes between low-carb and low-fat groups, the data held hidden clues about metabolic response. For the new analysis, Dr. Barad and her colleagues focused on 431 participants who had comprehensive genetic data available. The objective was to determine whether specific genotypes could predict how a person would respond to the increased intake of saturated fats often found in low-carb diets.
Phase 2: Building the Polygenic Score
Rather than looking at single genes—a common pitfall in early genetic research—the team utilized a polygenic score. This approach aggregates thousands of genetic variants across the genome to provide a holistic estimation of an individual’s genetic tendency toward higher or lower baseline LDL cholesterol.
Phase 3: Observing the Interaction
The researchers tracked the participants’ diets, their genetic predispositions, and the resulting changes in their LDL cholesterol over the first six months of the study. The results provided the "missing link" that researchers had been searching for: those with the highest genetic risk for high cholesterol showed the most significant LDL increases when their diets were heavy in saturated fat, but only within the low-carb cohort.
Supporting Data: The Impact of Saturated Fat
The core of the study’s finding is the interaction between saturated fat intake and genetic susceptibility. In the context of a low-carb diet, the restriction of carbohydrates often leads to an increased intake of fats, including saturated fats from animal products like butter, red meat, and processed meats.
The data revealed a clear correlation: participants who were genetically predisposed to higher LDL cholesterol were significantly more likely to experience a spike in these levels when following a low-carb diet. Crucially, this effect was not observed among the participants who were following a low-fat diet, suggesting that the combination of a low-carb environment and saturated fat intake acts as a specific trigger for those with a high genetic susceptibility.
This is a significant departure from previous research that looked at dietary components in isolation. It suggests that a person’s genetic "blueprint" determines how their body processes specific macronutrients, and that a diet deemed "healthy" for one person could be metabolically suboptimal for another based on their specific genetic profile.
Implications for Clinical Practice
The implications of this research are profound for the field of nutrition and personalized medicine. If clinicians can identify patients who are "saturated-fat sensitive," they can offer tailored dietary advice that maximizes the benefits of a low-carb diet while mitigating the cardiovascular risks.
Moving Beyond Genetic Testing
While the use of polygenic scores is a powerful research tool, Dr. Barad emphasizes that patients do not need expensive genetic testing to begin making better choices today. The most practical takeaway is the importance of monitoring. Because every body responds differently, patients should work with healthcare providers to track their cholesterol levels during any major dietary transition.
"Monitoring cholesterol may matter more than following one rigid rule," suggests Dr. Barad. If an individual decides to adopt a low-carb lifestyle, they should do so with a clear understanding of their baseline metrics and a plan to check those metrics periodically.
Reframing Low-Carb Nutrition
For those who wish to pursue a low-carb diet, the findings suggest a strategic shift in food selection. Rather than relying on high-saturated-fat foods like butter, beef tallow, or fatty cuts of meat, the research supports an emphasis on "healthy fats." Sources such as:
- Nuts and seeds (walnuts, chia, flax)
- Olive oil (extra virgin)
- Avocado
- Plant-based proteins
By prioritizing these unsaturated fats, individuals can reduce the likelihood of an unfavorable cholesterol response, regardless of their genetic makeup. This aligns with current dietary guidelines that recommend keeping saturated fat intake below 10% of total daily calories.
Future Research and Limitations
While these findings offer a new lens through which to view dietary responses, the researchers remain cautious. Because the findings were presented at a conference and have not yet undergone the full peer-review process required for journal publication, they should be considered preliminary.
Furthermore, the DIETFITS cohort—while robust—requires broader validation. Future studies will need to determine if these findings hold true across more diverse populations, including different ethnicities, age groups, and socioeconomic backgrounds. The complexity of the human genome and the myriad variables in human diet mean that this study is likely the first of many in the evolution of precision nutrition.
Conclusion: A New Era of Nutritional Awareness
The work presented at NUTRITION 2026 serves as a powerful reminder that our bodies are not standardized machines. We are the products of an intricate interplay between our environment—specifically what we eat—and our unique genetic legacy.
As we move forward, the conversation surrounding "good" and "bad" diets will likely become increasingly nuanced. By acknowledging that some individuals are more sensitive to saturated fats due to their genetic background, we can move toward a more compassionate, evidence-based, and personalized approach to health. For the millions of people navigating the complex world of dietary choices, this research provides not only a potential explanation for their past health outcomes but a roadmap for a safer, more effective future in nutrition.
The DIETFITS trial was funded by grant 1R01DK091831 from the National Institute of Diabetes and Digestive and Kidney Diseases; grants 1K12GM088033 and T32HL007034 from the National Heart, Lung, and Blood Institute; and the Stanford Clinical and Translational Science Award, grant UL1TR001085 from the National Institutes of Health. Dr. Alexa Barad was supported by the American Heart Association Postdoctoral Fellowship (26POST1542318).
